RecruitingLung Cancer Diagnosis

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Eligible age

50+ yrs

Accepts

All genders

Locations

22 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT).

Sponsor: Freenome Holdings Inc.

You may qualify if…

✓ 1. Age 50 years or older within 30 days of enrollment
✓ 2. Current or former smokers with a cumulative smoking history of ≥ 20 pack-year
✓ 3. Able to comprehend and willing to sign and date the informed consent and HIPAA authorization documents

You may not qualify if…

✕ 1. Any active therapy for cancer, including but not limited to surgery, chemotherapy, biologic therapy, immunotherapy, and/or radiation therapy at the time of enrollment
✕ 2. History of any malignancy within prior 5 years of enrollment (except for non- melanoma skin cancer)
✕ 3. History of organ, tissue, and bone marrow transplantation
✕ 4. Screened for lung cancer or having chest CT scan 12 months before enrollment
✕ 5. Having signs and symptoms of lung cancer such as hemoptysis, superior vena cava syndrome, Cushing syndrome, and Pancoast syndrome
✕ 6. Received a blood transfusion in the 30 days preceding enrollment
✕ 7. Known to be pregnant
✕ 8. Participated or currently participating in another Freenome-sponsored clinical study